April. 05, 2021 |
|
Nov. 01, 2021 |
|
jRCT2031210011 |
A phase II study to evaluate the efficacy and safety of M605106 short contact therapy in patients with acne vulgaris |
|
A phase II study of M605106 for acne vulgaris |
Nishiura Tomoyuki |
||
Maruho Co.,Ltd. Kyoto R&D Center |
||
93 chudoji Awatacho, Shimogyo-ku, Kyoto |
||
+81-75-325-3279 |
||
ctinfo@mii.maruho.co.jp |
||
- Clinical Trials Infomation |
||
Maruho Co.,Ltd. Kyoto R&D Center |
||
93 chudoji Awatacho, Shimogyo-ku, Kyoto |
||
+81-75-325-3279 |
||
ctinfo@mii.maruho.co.jp |
Not Recruiting |
April. 05, 2021 |
||
April. 01, 2021 | ||
240 | ||
Interventional |
||
randomized controlled trial |
||
double blind |
||
placebo control |
||
parallel assignment |
||
treatment purpose |
||
Patients with Acne vulgaris 12 to 49 years old |
||
- Patients with concurrent presense of serious cardiac, hepatic, renal, plumonary, hematologic, or other diseases considered inappropriate for paticipation in the clinical study |
||
12age old over | ||
49age old under | ||
Both |
||
Acne vulgaris |
||
Apply an appropriate amount once a day and remove after a short time. |
||
Percentage change in total lesion count after a certain period |
||
Maruho Co.,Ltd. |
Doujin Memorial Medical Foundation, Meiwa Hospital IRB | |
1-18,Kandasudacho,Chiyodaku, Tokyo | |
+81-3-5543-0196 |
|
jimukyoku@smo-msr.co.jp | |
Approval | |
No |
|
none |